영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - ibuprofen; codeine phosphate - oral tablet - 200mg ; 12.8mg

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - codeine phosphate - oral tablet - 30mg

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - codeine phosphate - oral tablet - 30mg

영국 - 영어 - myHealthbox

actavis group ptc ehf - codeine phosphate hemihydrate/paracetamol - film-coated tablets - 30/500mg - codeine, combinations excl. psycholeptics - for the relief of moderate to severe pain in adults and children above 12 years. codeine is indicated in patients older than 12 years of age for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen (alone).

영국 - 영어 - myHealthbox

actavis group ptc ehf - codeine phosphate hemihydrate/paracetamol - film-coated tablets - 60/1000mg - codeine, combinations excl. psycholeptics - for the relief of moderate to severe pain in adults and adolescents 16 years and older. codeine is indicated in patients 16 years and older for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen

미국 - 영어 - NLM (National Library of Medicine)

physicians total care, inc. - dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - dihydrocodeine bitartrate 32 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the relief of moderate to moderately severe pain. this combination product is contraindicated in persons with hypersensitivity to dihydrocodeine, codeine, acetaminophen, caffeine, or any of the inactive components listed above, or any situation where opioids are contraindicated including significant respiratory depression (in unmonitored settings or in the absence of resuscitative equipment), acute or severe bronchial asthma or hypercapnia, and paralytic ileus. this combination product is subject to the provisions of the controlled substance act, and has been placed in schedule iii. dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. like other opioid analgesics, dihydrocodeine may produce subjective effects other than analgesia (e.g., euphoria, relaxation), which may contribute to abuse by some patients. psychological dependence, physical dependence, and tolerance may d

미국 - 영어 - NLM (National Library of Medicine)

eon labs, inc. - carisoprodol (unii: 21925k482h) (carisoprodol - unii:21925k482h), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - carisoprodol 200 mg - carisoprodol, aspirin and codeine phosphate tablets, usp are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. limitations of use carisoprodol, aspirin and codeine phosphate tablets, usp should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration (see dosage and administration ). carisoprodol, aspirin and codeine phosphate tablets are contraindicated for: • all children younger than 12 years of age (see warnings) • post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ). carisoprodol, aspirin and codeine phosphate tablets are also contraindicated in patients with: carisoprodol, aspirin, and codeine phosphate tablets contains codeine. codeine in combination with carisoprodol and aspirin is a schedule iii

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - codeine phosphate - oral tablet - 15mg

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - codeine phosphate - oral tablet - 15mg

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - codeine phosphate - oral tablet - 15mg